NCT04742088

Brief Summary

Decathlon has developed ankleSOFT100 product which is medical device designed to reduce pain and joint instability during sport practice. The objective of this multicentre study is to collect data on the related clinical complications and clinical outcomes of market-approved Decathlon ankleSOFT100 product to demonstrate safety and performance of this device in a real-world setting.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable chronic-pain

Timeline
Completed

Started Mar 2021

Typical duration for not_applicable chronic-pain

Geographic Reach
1 country

4 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 4, 2020

Completed
5 months until next milestone

First Posted

Study publicly available on registry

February 5, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

March 17, 2021

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2023

Completed
Last Updated

September 14, 2022

Status Verified

September 1, 2022

Enrollment Period

2.1 years

First QC Date

September 4, 2020

Last Update Submit

September 12, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Functional score

    Change from baseline functional result (Cumberland Ankle Instability Tool: 0-30 points) at 6 weeks

    At baseline and 6 weeks of follow-up

Secondary Outcomes (4)

  • Confidence level

    At baseline and 6 weeks of follow-up

  • Ankle instability

    At 2 weeks and 6 weeks of follow-up

  • Ankle pain

    At 2 weeks and 6 weeks of follow-up

  • Safety (adverse events)

    6 weeks of follow-up

Study Arms (1)

Orthosis group

EXPERIMENTAL
Device: ankleSOFT100

Interventions

During the first two weeks of follow-up, the subject shall not use the device during the sports sessions. The subject shall use the device during the sports sessions for the next 4 weeks (6 weeks of follow-up)

Orthosis group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject is aged ≥18 years old
  • Subject has chronic pain AND / OR chronic ankle instability
  • The current condition of his/her ankle allows the subject to pursue a usual physical activity
  • Subject has been informed and is willing to sign an informed consent form
  • Subject is willing to comply with protocol requirements and return to the study center for all clinical evaluations and required follow-up (6 weeks)
  • Subject is affiliated to the French social security regime
  • Subject has conditions that may interfere with his/her ability to understand protocol requirements, participate in scheduled visits, or provide his/her informed consent
  • Subject has worn a support (ankle brace or articulated orthosis) during sports sessions during the last month
  • Subject has any medical condition that could impact the study at investigator's discretion
  • Subject has a known hypersensitivity or allergy to the components of the device (polyamide, elastodiene, elastane, polyester, synthetic rubber)
  • Adult subject to a legal protection measure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Centre de rééducation et de balnéothérapie Kinés Faches

Faches-Thumesnil, 59155, France

ACTIVE NOT RECRUITING

Centre Hospitalier Universitaire de Lille

Lille, 59000, France

RECRUITING

Cabinet de kinésithérapie du Belvédère

Paris, 75019, France

NOT YET RECRUITING

KOSS Paris 8

Paris, France

TERMINATED

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Valérie WIECZOREK

    Centre Hospitalier Universitaire de Lille

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2020

First Posted

February 5, 2021

Study Start

March 17, 2021

Primary Completion

May 1, 2023

Study Completion

May 1, 2023

Last Updated

September 14, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations